Kewaunee Scientific Corporation (NASDAQ:KEQU – Get Free Report) CEO Thomas David Hull III sold 1,000 shares of the stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $43.09, for a total value of $43,090.00. Following the completion of the transaction, the chief executive officer owned 38,719 shares of the company’s stock, valued at $1,668,401.71. The trade was a 2.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Thomas David Hull III also recently made the following trade(s):
- On Monday, September 29th, Thomas David Hull III sold 1,854 shares of Kewaunee Scientific stock. The stock was sold at an average price of $43.42, for a total value of $80,500.68.
- On Wednesday, September 24th, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $43.62, for a total value of $43,620.00.
- On Tuesday, September 23rd, Thomas David Hull III sold 721 shares of Kewaunee Scientific stock. The stock was sold at an average price of $44.00, for a total value of $31,724.00.
- On Friday, September 19th, Thomas David Hull III sold 773 shares of Kewaunee Scientific stock. The stock was sold at an average price of $45.34, for a total value of $35,047.82.
- On Thursday, September 18th, Thomas David Hull III sold 652 shares of Kewaunee Scientific stock. The stock was sold at an average price of $46.00, for a total value of $29,992.00.
Kewaunee Scientific Trading Down 2.0%
Shares of Kewaunee Scientific stock opened at $43.31 on Friday. The firm has a market capitalization of $124.13 million, a price-to-earnings ratio of 10.49 and a beta of 0.68. Kewaunee Scientific Corporation has a fifty-two week low of $30.33 and a fifty-two week high of $71.33. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.63 and a current ratio of 2.32. The stock has a 50 day moving average of $51.96 and a 200 day moving average of $45.29.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen upgraded Kewaunee Scientific from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th.
Get Our Latest Research Report on KEQU
Institutional Trading of Kewaunee Scientific
Several hedge funds have recently modified their holdings of KEQU. Punch & Associates Investment Management Inc. acquired a new stake in shares of Kewaunee Scientific in the first quarter valued at $788,000. American Century Companies Inc. raised its stake in shares of Kewaunee Scientific by 43.4% in the first quarter. American Century Companies Inc. now owns 49,182 shares of the technology company’s stock valued at $1,937,000 after acquiring an additional 14,889 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in shares of Kewaunee Scientific by 125.7% in the first quarter. Goldman Sachs Group Inc. now owns 19,397 shares of the technology company’s stock valued at $764,000 after acquiring an additional 10,803 shares in the last quarter. OMERS ADMINISTRATION Corp acquired a new stake in shares of Kewaunee Scientific in the first quarter valued at $284,000. Finally, Mink Brook Asset Management LLC acquired a new stake in shares of Kewaunee Scientific in the second quarter valued at $370,000. 32.69% of the stock is currently owned by institutional investors and hedge funds.
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
See Also
- Five stocks we like better than Kewaunee Scientific
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- General Dynamics Hits New Highs: Why It Might Keep Climbing
- What is Insider Trading? What You Can Learn from Insider Trading
- Nike’s Turnaround: If the Shoe Fits, Buy It!
- EV Stocks and How to Profit from Them
- NVIDIA Breaks Out to New Highs: What Comes Next?
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.